Dysfunction of the glymphatic system, particularly involving AQP4, is associated with various neurological disorders characterized by pathological solute accumulation, such as Aβ and Tau clearance in AD (Plog & Nedergaard, 2018). The gene discussed is MAPT; the disease is Alzheimer disease.